PharmD Capital Trading with PharmD_KS

PharmD Capital Trading with PharmD_KS

Share this post

PharmD Capital Trading with PharmD_KS
PharmD Capital Trading with PharmD_KS
Market Analysis for The Week Ahead
Copy link
Facebook
Email
Notes
More

Market Analysis for The Week Ahead

Week of 6/8/2025

PharmD_KS's avatar
PharmD_KS
Jun 07, 2025
∙ Paid
16

Share this post

PharmD Capital Trading with PharmD_KS
PharmD Capital Trading with PharmD_KS
Market Analysis for The Week Ahead
Copy link
Facebook
Email
Notes
More
2
Share

If you are looking to join the Discord please see here: JOIN THE DISCORD Please email help@pharmdcapital.com if there are any technical issues. The daily and weekly plans are posted in the Discord so the Discord option includes Substack content but a new Substack subscription does not include Discord access.

Be sure you have read the Starter Kit, including the free section even if you’re a paid subscriber. Trading Doggy Style Starter Kit

SPY 0.00%↑

Big picture, this week was all about the 3-week balance (large white rectangle below) with the immediate focus on the 5885-5893 to 5936-5940 consolidation range from last week. The week opened with a quick trap below 5885-5893, for which we were prepared with the daily plan for Monday:

If one were so inclined this was the swing long entry for the week as 5870.5 was the cash hours low of week.

Monday closed above 5936-5940 which triggered a test of the top of the balance (5987.5). Buyers struggled to gain much traction above 5987.5 and it led to a liquidation on Thursday which held the important 5936-5940 spot. We got a gap up on Friday and held above 5987.5 the entire day. The below is an RTH only chart with the last 4 weeks.

QQQ 0.00%↑ Additionally back tested and held its prior consolidation range on Thursday.

Bulls remain in full control until sellers accomplish my minimum criteria. Thursday may have looked ugly, but both indices held where they needed to and snapped back both during RTH Thursday and overnight Thursday night.

PAID CONTENT BELOW AND IN THE DISCORD

Subscribe Now

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2025 PharmD_KS
Market data by Intrinio
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share

Copy link
Facebook
Email
Notes
More